|
Volumn 57, Issue 6, 2000, Pages 455-458
|
Lidocaine as a protective agent during pancreas cold ischemia
a a a a a a |
Author keywords
cold ischemia; IDDM; Isles of Langerhans; Lidocaine; Pancreas; Transplantation
|
Indexed keywords
3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE;
BALANCED SALT SOLUTION;
COLLAGENASE;
GLUCOSE;
LIDOCAINE;
PHOSPHOLIPASE A2 INHIBITOR;
PROTECTIVE AGENT;
UNIVERSITY OF WISCONSIN SOLUTION;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CELL ACTIVITY;
CELL DAMAGE;
CELL ISOLATION;
CELL TRANSPLANTATION;
CELL VIABILITY;
COLD;
CONTROLLED STUDY;
DRUG EFFECT;
ENDOCRINE FUNCTION;
GLUCOSE METABOLISM;
INSULIN DEPENDENT DIABETES MELLITUS;
ISCHEMIA;
MALE;
MEMBRANE DAMAGE;
MEMBRANE STABILIZATION;
NONHUMAN;
ORGAN DONOR;
ORGAN PRESERVATION;
PANCREAS;
PANCREAS ISLET CELL;
PANCREAS ISLET TRANSPLANTATION;
PREMEDICATION;
PROTECTION;
PROVOCATION TEST;
RAT;
SAFETY;
ANIMALS;
COLD;
ISCHEMIA;
ISLETS OF LANGERHANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
LIDOCAINE;
MALE;
PANCREAS;
PROTECTIVE AGENTS;
RATS;
RATS, WISTAR;
|
EID: 0034508971
PISSN: 00016837
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (7)
|